Thomas Walter
Roche Diagnostics
15 Papers
101 Citations
Thomas Walter is an academic researcher from Roche Diagnostics. The author has contributed to research in topics: Dig & Nucleic acid. The author has an hindex of 6, co-authored 15 publications. Previous affiliations of Thomas Walter include Hoffmann-La Roche.
Chat about Author
Papers
Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase
TL;DR: A procedure for the nonradioactive labeling of oligonucleotides with the hapten digoxigenin (DIG) has been developed and the efficiency of the labeling reactions with respect to variation of the different parameters was analyzed.
344
Patent
System for providing biological materials
Gerhard Dr. Bienhaus,Michael Fritz,Juergen Schwab,Thomas Walter +3 more
- 06 Aug 1998
TL;DR: In this article, a process and closure arrangement for isolating purified biological material is provided for separating purified biological materials into separate lysis vessels, adding lysis liquids to the biological materials in the lysis vessel, and transferring the liquids in the Lysis vessels into a matrix unit.
32
Patent
Device for isolating nucleic acids
Thomas Walter,Michael Fritz,Herbert Dr. Harttig,Hans Lange,Rolf Lerch +4 more
- 29 Mar 1996
TL;DR: In this paper, the nucleic acid binding material is inserted through the outlet opening during the manufacture of the device and the outlet is narrowed in order to hold the binding material, which is particularly simple and reliable to manufacture but yet ensures that nucleic acids can be isolated without contamination.
26
Patent
Method for the repeated transfer of liquids
Gerhard Dr. Bienhaus,Hans Lange,Thomas Walter +2 more
- 12 Jun 1995
TL;DR: In this paper, a method for repeated transfer of liquids from one of several storage containers into a transfer container wherein protective tips are placed onto a tip of a pipette in order to avoid contamination is described.
12
Patent
Verfahren und vorrichtung zur reinigung von nukleinsäuren
Dirk Block,Ruediger Haenel,Joerg Kleiber,Manuela Poignee-Heger,Thomas Walter,Ralf Zielenski +5 more
- 15 Mar 2005
TL;DR: Disclosed as discussed by the authors is a device designed to isolate nucleic acids in such a way as to reduce the risk of contaminant transfer during such a process, which comprises two containers linked by a closing mechanism in which is placed an agent binding nucleic acid, said link being established by reversing the device.
8